Thuml News

This site has affiliate links.

Try This
Cluster: sciences

Stories below may also appear in other clusters. Data expires after 7 days.

LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
californiatelegraph.com Feb 5, 2026 8:45 p.m.
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
hawaiitelegraph.com Feb 5, 2026 6:30 p.m.
LIR Life Sciences Commences Project Phase 2 Peptide Design Program with Neuland Laboratories
tennesseedaily.com Feb 5, 2026 6:30 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
tennesseedaily.com Jan 29, 2026 8:15 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
hawaiitelegraph.com Jan 29, 2026 8:00 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
californiatelegraph.com Jan 29, 2026 7:45 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
newjerseytelegraph.com Jan 29, 2026 7:30 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Nove
pharmiweb.com Jan 29, 2026 7:30 p.m.
LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP - Enabled Transdermal Delivery of GLP / GIP - Based Therapies
torontotelegraph.com Jan 29, 2026 5:30 p.m.
Applied Visual Sciences ( OTCMKTS : APVS ) & Woodward ( NASDAQ : WWD ) Critical Analysis
dailypolitical.com Jan 18, 2026 4:30 p.m.
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
californiatelegraph.com Jan 15, 2026 7:30 p.m.
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
newjerseytelegraph.com Jan 15, 2026 5:45 p.m.
LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
tennesseedaily.com Jan 15, 2026 5:30 p.m.
Lir Life Sciences Corp .: LIR Life Sciences Launches Comparative Animal Study to Advance Transdermal Delivery of Second Generation GLP / GIP - based Obesity Therapies
finanznachrichten.de Jan 15, 2026 5:30 p.m.
Reviewing Establishment Labs ( NASDAQ : ESTA ) & Tauriga Sciences ( OTCMKTS : TAUG )
themarketsdaily.com Jan 11, 2026 5:00 a.m.
Lir Life Sciences Corp .: LIR Life Engages Neuland Labs to Advance Development of Cell Penetrating Peptides for Transdermal GLP - 1 / GIP Platform
finanznachrichten.de Jan 8, 2026 5:30 p.m.
Analyzing Establishment Labs ( NASDAQ : ESTA ) and Tauriga Sciences ( OTCMKTS : TAUG )
dailypolitical.com Jan 4, 2026 8:45 p.m.
Morgan Stanley Expects Gilead Sciences ( GILD ) to Thrive as Biopharma Policy Uncertainties Fade in 2026
finance.yahoo.com Dec 31, 2025 11:00 a.m.
Analyzing Cassava Sciences ( NASDAQ : SAVA ) and Reviva Pharmaceuticals ( NASDAQ : RVPH )
themarketsdaily.com Dec 28, 2025 3:15 a.m.
Reviewing Health Sciences Acquisitions Co . 2 ( NASDAQ : HSAQ ) & INVO Fertility ( NASDAQ : IVF )
tickerreport.com Dec 27, 2025 5:15 p.m.
Comparing INVO Fertility ( NASDAQ : IVF ) & Health Sciences Acquisitions Co . 2 ( NASDAQ : HSAQ )
dailypolitical.com Dec 27, 2025 5:15 p.m.